Clinical trial
Detection of Spinal Cord Lesions Using the MP2RAGE Sequence in Inflammatory Diseases of the Neuraxis
NCT06589999 is registered in ClinicalTrials.gov with Fondation Ophtalmologique Adolphe de Rothschild as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Detection of Spinal Cord Lesions Using the MP2RAGE Sequence in Inflammatory Diseases of the Neuraxis
- Lead sponsor
- Fondation Ophtalmologique Adolphe de Rothschild
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- July 31, 2024
- Completion date
- July 31, 2026
- Enrollment
- 196 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.